Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ)
CNY 8.45
(0.24%)
CNY 8.45
(0.24%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 244.25 Million | 387.27 Million | 101.81 Million | 206.66 Million | 239.54 Million | 314.02 Million |
| Net Income | -12.31 Million | 132.72 Million | 119.04 Million | 118.65 Million | 106.9 Million | 178.9 Million |
| Depreciation & Amortization | 135.18 Million | 123.62 Million | 115.95 Million | 113.06 Million | 112.76 Million | 79.8 Million |
| Deferred income taxes | 6.82 Million | 2.41 Million | -3.78 Million | -5.35 Million | -4.96 Million | 31.62 Million |
| Stock-based compensation | - | 939.83 Thousand | 12.35 Million | 1.47 Million | - | 11.28 Million |
| Change in working capital | 93.49 Million | 99.11 Million | -152.4 Million | -26.37 Million | 15.39 Million | 68.39 Million |
| Other non-cash items | 197.92 Million | 28.46 Million | 10.65 Million | 5.19 Million | 4.47 Million | -13.07 Million |
| Investing Cash Flow | -166.04 Million | -230.39 Million | 21.82 Million | -331.08 Million | -47.44 Million | -408.54 Million |
| Investments in PPE | -120.74 Million | -149.07 Million | -63.04 Million | -104.4 Million | -134.39 Million | -269.49 Million |
| Acquisitions | 953.48 Thousand | 384.12 Thousand | -35.93 Million | 105.07 Million | 135.39 Million | - |
| Investment purchases | -1.48 Billion | -1.11 Billion | -823.19 Million | -1.21 Billion | -607 Million | -698.76 Million |
| Sales/Maturities of investments | 1.39 Billion | 1.02 Billion | 943.5 Million | 988.39 Million | 692.94 Million | 551.51 Million |
| Other Investing Activities | 45.21 Million | 0.96 | 499.08 Thousand | -104.4 Million | -134.39 Million | 8.19 Million |
| Financing Cash Flow | -65.77 Million | 17.81 Million | -139.24 Million | 122.43 Million | -99.14 Million | -15.97 Million |
| Debt repayment | -30 Million | -40 Million | -132.34 Million | -21 Million | -7 Million | - |
| Dividends payments | -29.46 Million | -1.56 Million | -29.42 Million | -43.08 Million | -29.46 Million | -19.65 Million |
| Common Stock Repurchased | - | - | - | -4.93 Million | -70.85 Million | - |
| Common Stock Issuance | - | - | - | 57.67 Million | 70.85 Million | - |
| Other Financing Activities | -6.3 Million | 59.37 Million | 23.84 Million | 136.16 Million | -62.08 Million | 3.68 Million |
| Accounts receivables | 18.85 Million | 163.24 Million | -172.13 Million | -66.86 Million | 9.55 Million | 14.12 Million |
| Accounts payables | -13.08 Million | -56.54 Million | 87.16 Million | 26.51 Million | 18.3 Million | 39.5 Million |
| Inventory | 87.73 Million | -10 Million | -63.65 Million | 19.34 Million | -7.49 Million | -16.85 Million |
| Other working capital | -6.26 Million | 2.41 Million | -3.78 Million | -5.35 Million | -4.96 Million | 85.25 Million |
| Cash at beginning of period | 274.71 Million | 93.5 Million | 110.19 Million | 117.33 Million | 22.96 Million | 132.35 Million |
| Cash at end of period | 326.17 Million | 274.71 Million | 93.5 Million | 110.19 Million | 117.33 Million | 22.96 Million |
| Capital Expenditure | -120.74 Million | -149.07 Million | -63.04 Million | -104.4 Million | -134.39 Million | -269.49 Million |
| Effect of forex changes on cash | 7.07 Million | 6.51 Million | -1.08 Million | -5.15 Million | 1.41 Million | 1.09 Million |
| Net cash flow / Change in cash | 51.45 Million | 181.2 Million | -16.69 Million | -7.13 Million | 94.37 Million | -109.39 Million |
| Free Cash Flow | 123.51 Million | 238.2 Million | 38.76 Million | 102.25 Million | 105.15 Million | 44.52 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 9.37 Million | 23.8 Million | 28.68 Million | -12.31 Million | -58.74 Million | -9.69 Million |
| Depreciation & Amortization | - | 27.49 Million | 27.49 Million | 135.18 Million | 33.8 Million | -67.5 Million |
| Deferred income taxes | - | - | - | 6.82 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -17.24 Million | - | 93.49 Million | 106.58 Million | -88.28 Million |
| Other non-cash items | 61.76 Million | 49.29 Million | -28.38 Million | 197.92 Million | -48.06 Million | 200.76 Million |
| Investing Cash Flow | -70.32 Million | -19.55 Million | -61.17 Million | -166.04 Million | 10.87 Million | -6.81 Million |
| Investments in PPE | -27.75 Million | -28.66 Million | -33.33 Million | -120.74 Million | -47.21 Million | -19.81 Million |
| Acquisitions | 8.44 Million | -7.48 Million | 215.26 Thousand | 953.48 Thousand | 128.86 Thousand | 0.78 |
| Investment purchases | -347.21 Million | -422.82 Million | -216.82 Million | -1.48 Billion | -372.93 Million | -348.63 Million |
| Sales/Maturities of investments | 303.7 Million | 439.43 Million | 188.76 Million | 1.39 Billion | 385.69 Million | 361.62 Million |
| Other Investing Activities | 947.23 Thousand | 9.11 Million | -22.64 Million | 45.21 Million | 45.21 Million | - |
| Financing Cash Flow | -42.68 Million | -6.54 Million | -5.49 Million | -65.77 Million | 1.41 Million | -37.06 Million |
| Debt repayment | - | -10 Million | -600 Thousand | -30 Million | - | - |
| Dividends payments | -31.73 Million | -3.31 Million | -6.09 Million | -29.46 Million | -1.41 Million | -37.06 Million |
| Common Stock Repurchased | 13.23 Million | -13.23 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -10.95 Million | -3.31 Million | -6.09 Million | -6.3 Million | 30.88 Million | -37.06 Million |
| Accounts receivables | - | -2.1 Million | - | 18.85 Million | 18.85 Million | -11.6 Million |
| Accounts payables | - | - | - | -13.08 Million | - | - |
| Inventory | - | -15.14 Million | - | 87.73 Million | 87.73 Million | -76.68 Million |
| Other working capital | - | 110.00 | - | - | - | - |
| Cash at beginning of period | 242.03 Million | 229.94 Million | 326.17 Million | 274.71 Million | 275.99 Million | 254.32 Million |
| Cash at end of period | 193.14 Million | 242.03 Million | 244.64 Million | 326.17 Million | 326.17 Million | 245.79 Million |
| Capital Expenditure | -27.75 Million | -28.66 Million | -33.33 Million | -120.74 Million | -47.21 Million | -19.81 Million |
| Effect of forex changes on cash | 2.3 Million | 1.8 Million | 2.09 Million | 7.07 Million | 2.54 Million | 76.95 Thousand |
| Net cash flow / Change in cash | -48.88 Million | 12.09 Million | -81.52 Million | 51.45 Million | 50.17 Million | -8.53 Million |
| Free Cash Flow | 43.38 Million | 16.93 Million | -33.03 Million | 123.51 Million | -13.63 Million | 15.45 Million |
000831
002992
000425
WFC
PRFO
LOMA